- Home
- FTFT vs TTNP Comparison
FTFT vs TTNP Comparison
Compare FTFT & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- TTNP
- Stock Information
- Founded
- FTFT N/A
- TTNP 1991
- Country
- FTFT United States
- TTNP United States
- Employees
- FTFT N/A
- TTNP N/A
- Industry
- FTFT Business Services
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTFT Consumer Discretionary
- TTNP Health Care
- Exchange
- FTFT Nasdaq
- TTNP Nasdaq
- Market Cap
- FTFT 3.9M
- TTNP 3.4M
- IPO Year
- FTFT N/A
- TTNP 1996
- Fundamental
- Price
- FTFT $1.53
- TTNP $3.70
- Analyst Decision
- FTFT
- TTNP
- Analyst Count
- FTFT 0
- TTNP 0
- Target Price
- FTFT N/A
- TTNP N/A
- AVG Volume (30 Days)
- FTFT 82.2K
- TTNP 9.7K
- Earning Date
- FTFT 04-15-2025
- TTNP 05-14-2025
- Dividend Yield
- FTFT N/A
- TTNP N/A
- EPS Growth
- FTFT N/A
- TTNP N/A
- EPS
- FTFT N/A
- TTNP N/A
- Revenue
- FTFT $2,158,125.00
- TTNP N/A
- Revenue This Year
- FTFT N/A
- TTNP N/A
- Revenue Next Year
- FTFT N/A
- TTNP N/A
- P/E Ratio
- FTFT N/A
- TTNP N/A
- Revenue Growth
- FTFT N/A
- TTNP N/A
- 52 Week Low
- FTFT $1.15
- TTNP $3.03
- 52 Week High
- FTFT $9.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- FTFT 47.43
- TTNP 49.54
- Support Level
- FTFT $1.28
- TTNP $3.53
- Resistance Level
- FTFT $1.49
- TTNP $3.76
- Average True Range (ATR)
- FTFT 0.17
- TTNP 0.20
- MACD
- FTFT 0.05
- TTNP -0.00
- Stochastic Oscillator
- FTFT 86.36
- TTNP 32.79
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.